Skip to main content
. 2020 Nov 4;39(6):886–888. doi: 10.1016/j.vaccine.2020.10.094

Table 1.

Seroprevalence as per different demographic and comorbidity characteristics.

Group All Sero (−) Sero (+) % (+) 95% CI p value Odds ratio
All 801 712 89 11.1 9.1–13.5



Occupation
Ancillary workers 292 238 54 18.5 14.5–23.3 Odds = 0.227
Doctors 201 187 14 7.0 4.2–11.4 OR = 2.65
Nurses 308 287 21 6.8 4.5–10.2 OR = 2.71



Gender
Male 386 334 52 13.5 10.4–17.3 p = 0.04 OR = 1.51
Female 415 378 37 8.9 6.5–12.1



Age group
20–40 years 413 372 41 9.9 7.4–13.2 p = 0.54 OR = 0.803
40–60 years 380 333 47 12.4 9.4–16.1
>=60 years 8 7 1 12.5 2.2–47.1



Comorbidities
None 682 604 78 11.4 9.3–14.1 0.49
Single 103 94 9 8.7 4.5–16.0 0.62
Multiple 16 14 2 12.5 2.2–37.3
Cancer 5 4 1 20.0 2.0–64.0 0.94
Immunosuppression 11 9 2 18.2 4.0–48.9 0.45
Asthma 35 32 3 8.6 2.2–23.1 0.67
Cardiac problems 48 44 4 8.3 2.8–20.1 0.56
Diabetes mellitus 38 35 3 7.9 2.0–21.5 0.56